X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-25 | MNMD | Mind Medicine (Mindmed) Inc. | Karlin Dan | Chief Medical Officer | S - Sale | $9.50 | -6,578 | 358,452 | -2% | -$62,491 | ||||||
2024-03-25 | MNMD | Mind Medicine (Mindmed) Inc. | Barrow Robert | CEO | S - Sale | $9.50 | -16,519 | 580,202 | -3% | -$156,931 | ||||||
M | 2024-03-11 | UPXI | Upexi, Inc. | Marshall Allan | CEO, 10% | P - Purchase | $0.58 | +77,773 | 2,939,654 | +3% | +$44,739 | |||||
D | 2024-03-07 | MRMD | Marimed Inc. | Shaw Timothy | COO | S - Sale+OE | $0.23 | -15,348 | 10,477,072 | 0% | -$3,604 | |||||
D | 2024-03-07 | MRMD | Marimed Inc. | Levine Jon R | Pres, CEO | S - Sale+OE | $0.23 | -16,529 | 26,913,660 | 0% | -$3,881 | |||||
2024-03-11 | USNA | Usana Health Sciences Inc | Guest Kevin | EXEC. COB | S - Sale | $49.00 | -11,011 | 10,491 | -51% | -$539,539 | ||||||
2024-03-08 | USNA | Usana Health Sciences Inc | Noot Walter | COO | S - Sale | $49.05 | -5,240 | 0 | -100% | -$257,022 | ||||||
2024-03-06 | USNA | Usana Health Sciences Inc | Neidig Brent | CO., MAN. DIR. OF CHINA | S - Sale | $47.00 | -3,810 | 0 | -100% | -$179,066 | ||||||
2024-03-05 | UPXI | Upexi, Inc. | Marshall Allan | CEO, 10% | P - Purchase | $0.70 | +103,013 | 2,861,881 | +4% | +$72,109 | ||||||
2024-03-05 | USNA | Usana Health Sciences Inc | Sinnott Robert A | Chief Scientific Officer | S - Sale | $46.56 | -3,945 | 0 | -100% | -$183,659 | ||||||
2024-03-04 | USNA | Usana Health Sciences Inc | Fleming John Turman | Dir | S - Sale | $48.99 | -300 | 3,013 | -9% | -$14,696 | ||||||
2024-03-04 | USNA | Usana Health Sciences Inc | Fuller Gilbert A | Dir | S - Sale | $49.07 | -491 | 0 | -100% | -$24,096 | ||||||
2024-02-29 | USNA | Usana Health Sciences Inc | Pelosi Peggie | Dir | S - Sale | $48.15 | -485 | 3,138 | -13% | -$23,351 | ||||||
2024-03-01 | USNA | Usana Health Sciences Inc | Macuga Daniel A. | Chief Communications Officer | S - Sale | $48.08 | -1,500 | 3,791 | -28% | -$72,120 | ||||||
2024-02-29 | USNA | Usana Health Sciences Inc | Mulham David Mulham | Chief Sales Officer | S - Sale | $47.76 | -4,311 | 7,825 | -36% | -$205,872 | ||||||
2024-02-29 | USNA | Usana Health Sciences Inc | Foukas Joshua | GC | S - Sale | $47.91 | -4,847 | 0 | -100% | -$232,234 | ||||||
M | 2024-02-26 | CYAN | Cyanotech Corp | Jensen Glenn | VP, Operations | P - Purchase | $0.31 | +16,835 | 40,000 | +73% | +$5,222 | |||||
2024-01-17 | TLRY | Tilray Brands, Inc. | Faltischek Denise M | Chief Strategy Officer | P - Purchase | $2.05 | +10,000 | 293,269 | +4% | +$20,500 | ||||||
2024-01-16 | TLRY | Tilray Brands, Inc. | Gendel Mitchell | Global GC | P - Purchase | $1.98 | +7,200 | 195,796 | +4% | +$14,256 | ||||||
2024-01-12 | TLRY | Tilray Brands, Inc. | Gendel Mitchell | Global GC | P - Purchase | $1.87 | +5,400 | 188,596 | +3% | +$10,098 | ||||||
2024-01-12 | TLRY | Tilray Brands, Inc. | Simon Irwin D | Pres, CEO | P - Purchase | $1.88 | +53,700 | 2,033,058 | +3% | +$100,956 | ||||||
2024-01-12 | TLRY | Tilray Brands, Inc. | Merton Carl A | CFO | P - Purchase | $1.87 | +20,000 | 450,325 | +5% | +$37,400 | ||||||
2023-12-29 | CGC | Canopy Growth Corp | Yanofsky Theresa | Dir | S - Sale | $6.68 | -3,697 | 17,501 | -17% | -$24,696 | ||||||
2023-12-29 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Dir | S - Sale | $6.68 | -3,713 | 17,042 | -18% | -$24,803 | ||||||
2023-12-26 | MNMD | Mind Medicine (Mindmed) Inc. | Karlin Dan | Chief Medical Officer | S - Sale | $3.63 | -6,774 | 365,030 | -2% | -$24,590 | ||||||
2023-12-26 | MNMD | Mind Medicine (Mindmed) Inc. | Barrow Robert | CEO | S - Sale | $3.63 | -13,237 | 596,721 | -2% | -$48,050 | ||||||
2023-12-26 | MNMD | Mind Medicine (Mindmed) Inc. | Greenway Schond L. | CFO | S - Sale | $3.63 | -5,652 | 216,617 | -3% | -$20,517 | ||||||
M | 2023-12-15 | UPXI | Upexi, Inc. | Marshall Allan | CEO, 10% | P - Purchase | $0.96 | +12,916 | 2,767,249 | 0% | +$12,340 | |||||
2023-12-15 | FTLF | Fitlife Brands, Inc. | Ryan Patrick John Phillip | CHIEF RETAIL OFFICER | S - Sale | $24.50 | -4,000 | 10,544 | -28% | -$98,000 | ||||||
2023-12-15 | CYAN | Cyanotech Corp | Davis Michael A / | Dir, 10% | P - Purchase | $1.00 | +400,000 | 1,356,894 | +42% | +$400,000 | ||||||
2023-12-12 | USNA | Usana Health Sciences Inc | Fleming John Turman | Dir | S - Sale | $49.73 | -312 | 2,822 | -10% | -$15,515 | ||||||
2023-12-07 | UPXI | Upexi, Inc. | Marshall Allan | CEO, 10% | P - Purchase | $0.94 | +90,001 | 2,754,333 | +3% | +$84,952 | ||||||
M | 2023-12-04 | UPXI | Upexi, Inc. | Marshall Allan | CEO, 10% | P - Purchase | $0.76 | +53,474 | 2,664,332 | +2% | +$40,652 | |||||
2023-12-01 | CHUC | Charlie'S Holdings, Inc. | Carmines Edward | Dir | P - Purchase | $0.09 | +17,498 | 1,661,758 | +1% | +$1,575 | ||||||
2023-12-01 | CDXC | Chromadex Corp. | Gerber Brianna | CFO | P - Purchase | $1.41 | +5,000 | 28,674 | +21% | +$7,050 | ||||||
2023-12-01 | CYAN | Cyanotech Corp | Davis Michael A / | Dir, 10% | P - Purchase | $0.90 | +39,455 | 956,894 | +4% | +$35,510 | ||||||
2023-11-20 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Dir | S - Sale | $0.81 | -38,502 | 207,562 | -16% | -$31,187 | ||||||
2023-11-20 | CGC | Canopy Growth Corp | Yanofsky Theresa | Dir | S - Sale | $0.81 | -38,344 | 211,991 | -15% | -$31,059 | ||||||
2023-11-20 | CGC | Canopy Growth Corp | Schmeling Judy | Dir | S - Sale | $0.81 | -18,481 | 420,541 | -4% | -$14,970 | ||||||
2023-11-03 | USNA | Usana Health Sciences Inc | Fuller Gilbert A | Dir | S - Sale | $46.01 | -490 | 0 | -100% | -$22,546 | ||||||
D | 2023-10-27 | MRMD | Marimed Inc. | Levine Jon R | Pres, CEO, 10% | S - Sale+OE | $0.32 | -41,590 | 26,883,522 | 0% | -$13,350 | |||||
D | 2023-10-27 | MRMD | Marimed Inc. | Shaw Timothy | COO | S - Sale+OE | $0.32 | -33,272 | 10,449,087 | 0% | -$10,680 | |||||
E | 2023-09-28 | HYBT | Heyu Biological Technology Corp | Ang Ban Siong | Dir, 10% | S - Sale | $0.00 | -28,328,194 | 56,011,747 | -34% | -$28,328 | |||||
2023-09-25 | MNMD | Mind Medicine (Mindmed) Inc. | Barrow Robert | CEO | S - Sale | $3.58 | -13,499 | 611,729 | -2% | -$48,274 | ||||||
2023-09-25 | MNMD | Mind Medicine (Mindmed) Inc. | Karlin Dan | Chief Medical Officer | S - Sale | $3.57 | -6,918 | 371,804 | -2% | -$24,730 | ||||||
2023-09-25 | MNMD | Mind Medicine (Mindmed) Inc. | Greenway Schond L. | CFO | S - Sale | $3.58 | -5,762 | 222,269 | -3% | -$20,609 | ||||||
2023-09-18 | PLSH | Panacea Life Sciences Holdings, Inc. | Buttorff Leslie | CEO, 10% | P - Purchase | $0.24 | +20,000 | 1,533,949 | +1% | +$4,730 | ||||||
2023-09-15 | CYAN | Cyanotech Corp | Davis Michael A / | Dir, 10% | P - Purchase | $0.85 | +3,245 | 904,618 | 0% | +$2,742 | ||||||
M | 2023-09-13 | CYAN | Cyanotech Corp | Davis Michael A / | Dir, 10% | P - Purchase | $0.83 | +5,498 | 901,373 | +1% | +$4,564 | |||||
2023-09-12 | JUSH. | Jushi Holdings Inc. | Mosier Michelle O | CFO | P - Purchase | $0.70 | +30,567 | 97,067 | +46% | +$21,397 | ||||||
M | 2023-09-11 | CYAN | Cyanotech Corp | Davis Michael A / | Dir, 10% | P - Purchase | $0.82 | +399 | 895,875 | 0% | +$326 | |||||
2023-09-10 | BGXX | Bright Green Corp | Elmasri Saleem | CFO | P - Purchase | $0.00 | +500,000 | 1,000,000 | +100% | +$0 | ||||||
2023-09-07 | JUSH. | Jushi Holdings Inc. | Mosier Michelle O | CFO | P - Purchase | $0.75 | +66,500 | 66,500 | New | +$49,875 | ||||||
M | 2023-09-07 | CYAN | Cyanotech Corp | Davis Michael A / | Dir, 10% | P - Purchase | $0.75 | +20,453 | 895,476 | +2% | +$15,375 | |||||
M | 2023-09-06 | FFNTF | 4Front Ventures Corp. | Gontmakher Leonid | CEO | P - Purchase | $0.23 | +95,000 | 41,473,411 | 0% | +$21,645 | |||||
M | 2023-09-05 | CYAN | Cyanotech Corp | Davis Michael A / | Dir, 10% | P - Purchase | $0.67 | +18,520 | 875,023 | +2% | +$12,353 | |||||
2023-09-06 | CDXC | Chromadex Corp. | Champion River Ventures Ltd | Dir, 10% | P - Purchase | $0.00 | +3,467,778 | 11,408,715 | +44% | +$0 | ||||||
2023-09-01 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Dir | S - Sale | $0.71 | -38,963 | 246,064 | -14% | -$27,664 | ||||||
2023-09-01 | CGC | Canopy Growth Corp | Schmeling Judy | Dir | S - Sale | $0.71 | -18,703 | 439,022 | -4% | -$13,279 | ||||||
2023-09-01 | CGC | Canopy Growth Corp | Yanofsky Theresa | Dir | S - Sale | $0.71 | -38,803 | 250,335 | -13% | -$27,550 | ||||||
D | 2023-08-31 | BGXX | Bright Green Corp | Stockwell Lynn | Dir, 10% | S - Sale+OE | $0.47 | -250,000 | 69,183,658 | 0% | -$116,675 | |||||
2023-08-29 | FFNTF | 4Front Ventures Corp. | Gontmakher Leonid | CEO | P - Purchase | $0.13 | +14,500 | 32,078,161 | 0% | +$1,813 | ||||||
2023-08-30 | MTEX | Mannatech Inc | Bala Alfredo | CEO, Pres | S - Sale | $12.40 | -1,000 | 3,137 | -24% | -$12,400 | ||||||
2023-08-25 | MNMD | Mind Medicine (Mindmed) Inc. | Greenway Schond L. | CFO | S - Sale | $3.80 | -20,000 | 228,031 | -8% | -$76,000 | ||||||
2023-08-18 | MTEX | Mannatech Inc | Jobe Larry A | Dir | S - Sale | $12.82 | -1,217 | 67,089 | -2% | -$15,602 | ||||||
2023-08-17 | USNA | Usana Health Sciences Inc | Winssinger Frederic J | Dir | S - Sale | $63.84 | -930 | 1,703 | -35% | -$59,372 | ||||||
2023-08-15 | USNA | Usana Health Sciences Inc | Mulham David Mulham | Chief Sales Officer | S - Sale | $65.34 | -2,159 | 5,448 | -28% | -$141,067 | ||||||
2023-08-11 | USNA | Usana Health Sciences Inc | Mulham David Mulham | Chief Sales Officer | S - Sale | $66.28 | -1,080 | 7,607 | -12% | -$71,585 | ||||||
2023-08-01 | USNA | Usana Health Sciences Inc | Fuller Gilbert A | Dir | S - Sale | $64.43 | -265 | 0 | -100% | -$17,075 | ||||||
2023-07-31 | USNA | Usana Health Sciences Inc | Fuller Gilbert A | Dir | S - Sale | $65.01 | -226 | 265 | -46% | -$14,693 | ||||||
2023-07-31 | USNA | Usana Health Sciences Inc | Mulham David Mulham | Chief Sales Officer | S - Sale | $65.00 | -3,354 | 8,687 | -28% | -$218,010 | ||||||
2023-07-28 | USNA | Usana Health Sciences Inc | Jones Paul A. | Chief People Officer | S - Sale | $65.00 | -3,682 | 3,353 | -52% | -$239,330 | ||||||
2023-07-27 | USNA | Usana Health Sciences Inc | Ding Xia | Dir | S - Sale | $65.60 | -606 | 1,421 | -30% | -$39,753 | ||||||
2023-06-27 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Dir | S - Sale | $0.62 | -3,872 | 17,170 | -18% | -$2,401 | ||||||
D | 2023-06-27 | CGC | Canopy Growth Corp | Stewart Thomas Carlton | Chief Accounting Officer | S - Sale+OE | $0.62 | -19,667 | 14,245 | -58% | -$12,194 | |||||
D | 2023-06-30 | CGC | Canopy Growth Corp | Klein David Eric | CEO | S - Sale+OE | $0.52 | -18,775 | 173,302 | -10% | -$9,763 | |||||
2023-06-27 | CGC | Canopy Growth Corp | Yanofsky Theresa | Dir | S - Sale | $0.62 | -3,856 | 21,281 | -15% | -$2,391 | ||||||
2023-06-27 | CGC | Canopy Growth Corp | Schmeling Judy | Dir | S - Sale | $0.62 | -1,859 | 55,939 | -3% | -$1,153 | ||||||
D | 2023-06-30 | CGC | Canopy Growth Corp | Hong Judy Eun Joo | CFO | S - Sale+OE | $0.52 | -1,087 | 4,013 | -21% | -$565 | |||||
M | 2023-06-22 | UPXI | Upexi, Inc. | Marshall Allan | CEO, 10% | P - Purchase | $2.36 | +79,945 | 2,690,803 | +3% | +$188,783 | |||||
M | 2023-06-29 | MTEX | Mannatech Inc | Bala Alfredo | CEO, Pres | S - Sale | $12.77 | -269 | 4,137 | -6% | -$3,436 | |||||
2023-07-05 | BTMD | Biote Corp. | Conlon Mary Elizabeth | GC | S - Sale | $6.50 | -6,240 | 140,393 | -4% | -$40,573 | ||||||
2023-06-27 | MNMD | Mind Medicine (Mindmed) Inc. | Barrow Robert | CEO | S - Sale | $3.20 | -15,502 | 623,457 | -2% | -$49,620 | ||||||
2023-06-27 | MNMD | Mind Medicine (Mindmed) Inc. | Karlin Dan | Chief Medical Officer | S - Sale | $3.20 | -6,783 | 378,722 | -2% | -$21,697 | ||||||
2023-06-27 | MNMD | Mind Medicine (Mindmed) Inc. | Greenway Schond L. | CFO | S - Sale | $3.20 | -11,635 | 248,031 | -4% | -$37,194 | ||||||
2023-06-15 | USNA | Usana Health Sciences Inc | Mulham David Mulham | Chief Sales Officer | S - Sale | $61.00 | -1,557 | 12,041 | -11% | -$94,977 | ||||||
2023-06-14 | USNA | Usana Health Sciences Inc | Macuga Daniel A. | Chief Communications Officer | S - Sale | $62.88 | -2,234 | 778 | -74% | -$140,474 | ||||||
2023-06-12 | CDXC | Chromadex Corp. | Jaksch Frank L Jr | Dir | P - Purchase | $1.69 | +7,000 | 2,306,391 | 0% | +$11,830 | ||||||
2023-06-09 | PLSH | Panacea Life Sciences Holdings, Inc. | Buttorff Leslie | CEO, 10% | P - Purchase | $0.43 | +3,000 | 1,513,949 | 0% | +$1,298 | ||||||
2023-05-31 | CDXC | Chromadex Corp. | Fried Robert N | CEO | P - Purchase | $1.42 | +7,000 | 1,580,061 | 0% | +$9,940 | ||||||
2023-05-30 | CRON | Cronos Group Inc. | Adler Jason Marc | Dir | P - Purchase | $1.74 | +37,500 | 2,003,320 | +2% | +$65,074 | ||||||
E | 2023-05-17 | HYBT | Heyu Biological Technology Corp | Tan Hung Seng | Dir | P - Purchase | $0.00 | +20,000,000 | 70,000,000 | +40% | +$20,000 | |||||
2023-05-25 | CRON | Cronos Group Inc. | Adler Jason Marc | Dir | P - Purchase | $1.80 | +100,000 | 1,965,820 | +5% | +$179,650 | ||||||
2023-05-25 | CDXC | Chromadex Corp. | Rubin Steven D | Dir | P - Purchase | $1.46 | +7,000 | 7,000 | New | +$10,220 | ||||||
2023-05-23 | CRON | Cronos Group Inc. | Adler Jason Marc | Dir | P - Purchase | $1.90 | +100,000 | 1,865,820 | +6% | +$190,220 | ||||||
E | 2023-05-17 | HYBT | Heyu Biological Technology Corp | Ang Ban Siong | CEO, Pres, 10% | S - Sale | $0.00 | -68,645,429 | 843,399,410 | -8% | -$68,645 | |||||
M | 2023-05-19 | PLSH | Panacea Life Sciences Holdings, Inc. | Buttorff Leslie | CEO, 10% | P - Purchase | $0.51 | +6,500 | 9,069,176 | 0% | +$3,324 | |||||
2023-05-19 | CRON | Cronos Group Inc. | Adler Jason Marc | Dir | P - Purchase | $1.89 | +100,000 | 1,765,820 | +6% | +$189,010 | ||||||
2023-05-22 | UPXI | Upexi, Inc. | Marshall Allan | CEO, 10% | P - Purchase | $3.41 | +22,776 | 2,610,858 | +1% | +$77,739 | ||||||
M | 2023-05-17 | CRON | Cronos Group Inc. | Adler Jason Marc | Dir | P - Purchase | $1.73 | +70,720 | 1,665,820 | +4% | +$122,045 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |